Men's Health
Opinion
The male biological clock – How to tell the time
For all ages, studies have suggested that elevated male body mass index as well as alcohol consumption and cigarette smoking, including e-...
Conference Coverage
Although inconclusive, CV safety study of cancer therapy attracts attention
Even though PRONOUNCE, a trial comparing prostate cancer drugs for cardiovascular safety couldn’t reach a conclusion, it may prove to be a model...
Commentary
‘Countdown to zero’: Endocrine disruptors and worldwide sperm counts
A urologist makes the case that everyday chemicals are behind the ongoing decline in sperm counts seen in Western countries.
Conference Coverage
Testosterone replacement shows CV benefit in hypogonadal men
Among men with hypogonadism who received testosterone replacement every 3 months, cardiovascular parameters were better and there were fewer...
Feature
Most U.S. adults age 50+ report good health: Survey
Among the respondents, 41% said their health was very good or excellent.
Conference Coverage
'Full throttle': 'Diabetes Garage' workshops boost Mexican American men's self-management
Infusing diabetes education with concepts and lingo from car culture is a promising approach to improving self-management behaviors, and might...
From the Journals
Eating more fat may boost borderline low testosterone
“If somebody has low testosterone, particularly borderline, they could try increasing their fat intake, maybe on a Mediterranean diet, and see if...
From the Journals
Risk for erectile dysfunction sixfold higher in men with COVID-19
The finding “gives a whole new meaning to wearing the mask – mask up to keep it up.”
Conference Coverage
PCOS equivalent in men: No ovaries required
From the Journals
Testosterone decline after steroid abuse revealed with new biomarker
Reduced insulinlike factor 3 levels could track damage to Leydig cells and lead to potential treatments.
Feature
BMI, age, and sex affect COVID-19 vaccine antibody response
Study finds that older and heavier men have lower antibody responses to the Pfizer mRNA vaccine than do younger, leaner, and female recipients.